Management of achalasia: Surgery or pneumatic dilation

Gut

Volumn 60, Issue 6, 2011, Pages 869-876

  Richter, Joel E ^a   Boeckxstaens, Guy E ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BOTULINUM TOXIN A; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; NITRATE; PLACEBO; PROTON PUMP INHIBITOR;

ASPIRATION PNEUMONIA; BALLOON DILATATION; BARIUM MEAL; CARDIOESOPHAGOMYOTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE INCREASE; DRUG POTENTIATION; DYSPHAGIA; ECHOGRAPHY; ENDOSCOPY; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS MYOTOMY; ESOPHAGUS PERFORATION; FLUOROSCOPY; GASTROESOPHAGEAL REFLUX; GENE; HEARTBURN; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LOWER ESOPHAGUS SPHINCTER PRESSURE; MAJOR HISTOCOMPATIBILITY COMPLEX GENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; STOMACH FUNDOPLICATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORACOTOMY; THORAX PAIN;

ALGORITHMS; BALLOON DILATION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; HUMANS; LAPAROSCOPY; NEUROMUSCULAR AGENTS;

EID: 79955804221     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.212423     Document Type: Review

References (55)

1. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002;47:15-19. (Pubitemid 34075010)
2. Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008;103:1598-609.
3. Boeckxstaens GE. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol 2008;103:1610-12.
4. Howard PJ, Maher L, Pryde A, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992;33:1011-15.
5. Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008;135:1526-33.
6. Gockel I, Eckardt VF, Schmitt T, et al. Pseudoachalasia: a case series and analysis of the literature. Scand J Gastroenterol 2005;40:378-85. (Pubitemid 40546904)
7. Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999;116:1300-4. (Pubitemid 29258877)
8. Vela MF, Richter JE. Management of achalasia at a tertiary center-a complicated disease. Gastroenterology 2003;124:S1635.
9. Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992;103:1732-8.
10. Kadakia SC, Wong RK. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 1993;88:34-8. (Pubitemid 23017939)
11. Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010;8:30-5.
12. Vela M, Richter JE, Khandwala E, et al. The long-term efficacy of pneumatic dilation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006;4:580-7.
13. Richer JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008;2:435-45.
14. Zerbib F, Thetiot V, Richy F, et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006;101:692-7.
15. Vantrappen G, Hellemans J, Deloof W, et al. Treatment of achalasia with pneumatic dilation. Gut 1971;12:268-75.
16. Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective longterm follow-up study. Gastrointest Endosc 1997;45:349-53. (Pubitemid 27426173)
17. Ghoshal UC, Kumar S, Saraswat VA, et al. Long-term follow-up after pneumatic dilation for achalasia of the cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004;99:2304-10. (Pubitemid 40039357)
18. Vaezi MF, Baker MF, Achkar E, et al. Timed barium esophagram: better predictor of long-term success after pneumatic dilation than symptoms assessment. Gut 2002;50:765-70. (Pubitemid 34539036)
19. O'Connor JB, Singer ME, Richter JE, et al. The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci 2002;47:1516-25. (Pubitemid 34753931)
20. Karanicolas PJ, Smith SE, Gafni A, et al. The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia. Surg Endosc 2007;21:1198-206. (Pubitemid 47024780)
21. Guardino J, Vela M, Connor J, et al. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol 2004;38:855-60. (Pubitemid 39410944)
22. Metman EH, Lagasse JP, d'Alteroche L, et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 1999;94:1179-85.
23. Boeckxstaens GE, Annese V, Bruley des Varannes S, et al. Pneumodilation versus laparoscopic Heller myotomy for idiopathic achalasia. N Engl J Med 2010 (in press).
24. Heller E. Extramukoese cardinplastik bein chronischen cardiopsasmus mit dilation des oesophagus. Mitt Grenzgeb Med Chir 1914;27:141-5.
25. Pelligrini C, Wetter LA, Patti M, et al. Thoracoscopic esophagomyotomy. Initial experience with a new approach for achalasia. Ann Surg 1992;216:291-6.
26. Oelschlager BK, Chang L, Pellegrini CA. Improved outcomes after extended gastric myotomy for achalasia. Arch Surg 2003;138:490-5.
27. Richards W, Torquati A, Holzman M, et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg 2004;240:405-15. (Pubitemid 39121335)
28. Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatment for achalasia. A systemic review and meta-analysis. Ann Surg 2009;249:45-57.
29. Constantini MI, Zanninotta G, Guirroli E, et al. The laparoscopic- Dor operation remains effective treatment for achalasia at a minimum of 6 years follow-up. Surg Endosc 2005;19:345-51. (Pubitemid 40897931)
30. Portale G, Constantini M, Rizzetto C, et al. Long term outcome of laparoscopic Heller-Dor surgery for achalasia: possible detrimental role of previous endoscopic treatment. J Gastrointest Surg 2005;9:1332-9. (Pubitemid 41751128)
31. Schuchert MJ, Lubetich JD, Landreneau RJ, et al. Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcome. Ann Thorac Surg 2008;85:1729-34. (Pubitemid 351608147)
32. Snyder CW, Burton RC, Brown LE, et al. Multiple preoperative endoscopic interventions are associated with worse outcome after laparoscopic Heller myotomy for achalasia. J Gastrointest Surg 2009;13:2095-103.
33. Grockel I, Junginger T, Eckardt V. Long-term results of conventional myotomy in patients with achalasia: a prospective 20 year analysis. J Gastrointest Surg 2006;10:1400-8. (Pubitemid 44920298)
34. Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg 2005;190:874-8. (Pubitemid 41674615)
35. Patti MG, Feo CV, Diener U, et al. Laparoscopic Heller myotomy relieves dysphagia in achalasia when the esophagus is dilated. Surg Endosc 1999;13:843-6.
36. Mineo TC, Pompeo E. Long-term outcome of Heller myotomy in achalasic sigmoid esophagus. J Thorac Cardiovasc Surg 2004;128:402-7. (Pubitemid 39194696)
37. Eldaif SM, Mutrie C, Rutledge WC, et al. The risk of esophageal resection after esophagomyotomy for achalasia. Ann Thorac Surg 2009;87:1858-63.
38. Sharp KW, Khaitan L, Scholz S, et al. 100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg 2002;235:631-9. (Pubitemid 34454150)
39. Csendes A, Braghetto I, Burdiles P, et al. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg 2006;243:196-203. (Pubitemid 43185438)
40. Lopushinsky SR, Urbach DR. Pneumatic dilation and surgical myotomy for achalasia. JAMA 2006;296:2227-33. (Pubitemid 44708053)
41. Shimi S, Nathanson LK, Cuschieri A. Laparoscopic cardiomyotomy for achalasia. J R Coll Surg Edinb 1991;36:152-4.
42. Boeckxstaens GE, Annese V, Bruley des Varannes S, et al. Pneumodilation versus laparoscopic Heller myotomy for idiopathic achalasia. New Engl J Med, in press.
43. Richter JE. A young man with a new diagnosis of achalasia. Clin Gastroenterol Hepatol 2008;6:859-63.
44. Hoogerwerf WA, Pasricha PJ. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin North Am 2001;11:311-23. (Pubitemid 32472550)
45. Annese V, Bassotti G, Coccia G, et al. A multicenter randomized study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gut 2000;46:597-600. (Pubitemid 30305774)
46. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictor of response. Gastroenterology 1996;110:1410-15. (Pubitemid 26134072)
47. Vaezi MJ, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilation in the treatment of achalasia: a randomized trial. Gut 1999;44:231-9. (Pubitemid 29119367)
48. Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996;91:1724-30. (Pubitemid 26307172)
49. Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 2001;15:1389-96. (Pubitemid 32835546)
50. Panaccione R, Gregor JC, Reynolds RPE, et al. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest Endosc 1999;50:492-8. (Pubitemid 29480775)
51. Micci MA, Learish RD, Li H, et al. Neural stem cells express RET, produce nitric oxide, and survive transplantation in the gastrointestinal tract. Gastroenterology 2001;121:757-66. (Pubitemid 32959385)
52. Momin EN, Mohyeldin A, Zaidi HA, et al. Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther 2010;5:326-44.
53. Metzger M, Caldwell C, Barlow AJ, et al. Enteric nervous system stem cells derived from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology 2009;136:2214-25.
54. Bravi I, Nicita MT, Duca P, et al. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment Pharmacol Ther 2010;31:658-65.
55. Chen Z, Bessell JR, Chew A, et al. Laparoscopic cardiomyotomy for achalasia: clinical outcomes beyond 5 years. J Gastrointest Surg 2010;14:594-600.